Overview Request Sample Pages Request Customization Download PDF
You are viewing: Italy Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Italy Gastrointestinal Stent Market was valued at $21.62 Million in 2026 and projected to reach to $27.95 Million by 2031, representing a compound annual growth rate of 5.3%. Italy's gastrointestinal stent market is positioned for steady growth through 2031, supported by an aging population with increasing gastrointestinal complications and a robust healthcare infrastructure committed to minimally invasive interventions.

Italy Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Italy Gastrointestinal Stent Market Trends and Insights

  • Italy's healthcare infrastructure and aging population drive demand for minimally invasive gastrointestinal interventions, positioning the country as a significant market within Europe.
  • The Italian market benefits from advanced medical device adoption and strong reimbursement frameworks that support endoscopic stent procedures. Growth in Italy's gastrointestinal stent market is underpinned by rising prevalence of esophageal and biliary disorders, coupled with increasing patient preference for less invasive treatment options.
  • Italy's established healthcare system and clinical expertise in gastroenterology support steady market expansion through 2031.
  • Key drivers include an aging demographic, improved diagnostic capabilities, and growing awareness of stent-based therapies among Italian healthcare providers and patients..

Key Market Statistics

  • CAGR (2026-2031) 5.3% CAGR
  • Market Size, 2026 ~USD 21.62 Million
  • Forecast, 2031 ~USD 27.95 Million
  • Country Italy

Italy Gastrointestinal Stent Market Overview

Market Valuation Growth :

Italy's gastrointestinal stent market is valued at USD 21.62 million in 2026 and is projected to reach USD 27.95 million by 2031, demonstrating steady expansion driven by healthcare modernization and procedural adoption.

Aging Population Dynamics :

Italy's demographic shift toward an older population increases prevalence of gastrointestinal disorders, creating sustained demand for minimally invasive stent interventions and driving market growth at 5.3% CAGR.

Healthcare Infrastructure Strength :

Italy's advanced healthcare system and well-established medical device distribution networks support widespread adoption of gastrointestinal stents across hospitals and specialized endoscopy centers throughout the country.

European Market Position :

As a significant European market, Italy represents a key growth opportunity within the continent, with healthcare spending and regulatory frameworks supporting innovation in minimally invasive gastrointestinal procedures.

Italy Gastrointestinal Stent Market Dynamics

  • The 5.3% CAGR reflects consistent demand from hospitals and endoscopy centers seeking advanced stent solutions for biliary, esophageal, and colorectal applications.
  • Healthcare reimbursement policies and clinical adoption of newer stent technologies will further accelerate market expansion.
  • Italy's strong medical device sector and emphasis on patient outcomes create favorable conditions for market players to introduce innovative products and expand their market presence..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Italy's gastrointestinal stent market reaches USD 21.62 million in 2026 and grows to USD 27.95 million by 2031 at a 5.3% CAGR.
    • Italy's aging population and high prevalence of gastrointestinal disorders fuel demand for minimally invasive stent interventions.
    • Italy's robust healthcare reimbursement system and clinical expertise in endoscopy support sustained market growth.
    • Italy's market benefits from increasing adoption of self-expanding metal stents and biodegradable stent technologies.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Italy Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS1.81.922.12.22.42.52.65.8
    HOSPITALS & CLINICS13.514.114.815.516.317.117.918.95
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS4.34.64.85.15.45.76.16.45.9
    TOTAL19.620.621.622.723.925.226.527.95.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers seeking to expand or establish presence in Italy need detailed market sizing, growth projections, and competitive insights to guide product launches and market penetration strategies in this key European market.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Italian healthcare require country-specific market data, growth trajectories, and demographic drivers to assess portfolio companies and identify acquisition targets in the GI stent sector.
    • Hospital & Clinic Administrators : Healthcare facility leaders in Italy need market intelligence on stent adoption trends, reimbursement landscapes, and procurement strategies to optimize inventory management and clinical outcomes for gastrointestinal interventions.
    • Distributors & Suppliers : Medical device distributors operating in Italy require market forecasts and demand projections to optimize supply chain planning, inventory levels, and partnership strategies with hospitals and endoscopy centers.
    • Market Consultants & Analysts : Research professionals and consultants advising healthcare clients need Italy-specific market data and insights to support strategic recommendations, competitive analysis, and market opportunity assessments for stakeholders.

    Key Companies in the Italy Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for Italy's gastrointestinal stent market (USD 21.62M in 2026, USD 27.95M in 2031) with country-specific CAGR of 5.3% to inform investment and expansion decisions.
    • Demographic Insights for Italy : Understand Italy's aging population dynamics and their direct correlation to gastrointestinal disorder prevalence, enabling targeted product development and market entry strategies tailored to Italian patient demographics.
    • Competitive Landscape Analysis : Gain intelligence on Italy-specific market dynamics, healthcare infrastructure capabilities, and regional competitive positioning to identify growth opportunities and differentiation strategies within the Italian market.
    • Regulatory & Reimbursement Framework : Leverage Italy-focused insights on healthcare reimbursement policies, regulatory pathways, and clinical adoption trends to navigate market entry and optimize product commercialization strategies.
    • Strategic Market Planning : Utilize country-specific forecasts and market intelligence to develop targeted go-to-market strategies, resource allocation plans, and partnership opportunities within Italy's gastrointestinal stent sector.

    Frequently asked questions

    What is the market size of gastrointestinal stents in Italy?

    Italy's gastrointestinal stent market is valued at USD 21.62 million in 2026 and is forecast to reach USD 27.95 million by 2031.

    What is the growth rate of Italy's gastrointestinal stent market?

    Italy's gastrointestinal stent market is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2031.

    What factors drive growth in Italy's gastrointestinal stent market?

    Key growth drivers in Italy include an aging population, rising prevalence of esophageal and biliary disorders, strong healthcare reimbursement, and increasing adoption of minimally invasive endoscopic procedures.

    Which stent types are most commonly used in Italy?

    Italy's market is dominated by self-expanding metal stents (SEMS) for esophageal and biliary applications, with growing adoption of plastic stents and emerging biodegradable technologies.

    How does Italy's market compare to other European countries?

    Italy represents a significant European market for gastrointestinal stents, supported by advanced healthcare infrastructure, high clinical expertise, and favorable reimbursement policies that align with broader European market trends.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status